broadli
neutral
antibodi
bnab
wide
thought
repres
best
mean
prevent
hiv
infect
make
develop
immunogen
capabl
rais
bnab
cornerston
prioriti
vaccin
develop
effort
unfortun
variou
factor
relat
characterist
known
bnab
well
hiv
viru
point
toward
substanti
obstacl
realiz
goal
sequenc
divers
instabl
trimer
heavili
glycosyl
structur
low
surfac
densiti
viral
particl
limit
access
function
critic
epitop
confound
effort
induc
bnab
vaccin
furthermor
cue
natur
infect
suggest
monoclon
bnab
uncommon
aris
year
infect
high
viral
load
fail
control
establish
infect
must
precis
orient
bind
interact
often
unusu
properti
indic
without
fundament
breakthrough
immunogen
design
gener
bnab
vaccin
like
remain
daunt
challeng
even
excit
progress
achiev
recent
character
neutral
capac
antibodi
gener
cours
natur
infect
well
identifi
novel
bnab
bnab
greatli
inform
immunogen
design
highlight
new
region
envelop
trimer
variabl
loop
envelop
glycan
membran
proxim
region
novel
quaternari
epitop
receptor
coreceptor
bind
site
epitop
combin
suffici
conserv
function
relev
key
target
effect
antibodi
respons
anticip
continu
use
highthroughput
bcell
screen
method
set
bnab
differ
fineepitop
specif
viral
coverag
continu
grow
provid
rich
set
probe
reinvigor
diversifi
immunogen
design
effort
howev
highthroughput
adapt
platform
requir
ensur
find
effici
translat
candid
immunogen
develop
context
natur
infect
bnab
tend
isol
individu
high
viral
load
persist
antigen
exposur
progress
diseas
absenc
replic
vector
difficult
envis
similar
level
antigen
exposur
could
accomplish
via
vaccin
addit
envelop
divers
may
key
driver
gener
neutral
breadth
pose
anoth
fundament
challeng
togeth
antigen
exposur
associ
natur
infect
like
repres
order
magnitud
greater
level
divers
achiev
current
strategi
lead
discourag
conclus
success
immunogen
may
need
possess
order
magnitud
improv
capac
elicit
bnab
natur
envelop
technic
immunolog
gap
mind
sought
establish
yeast
surfac
display
ysd
platform
appli
direct
molecular
evolut
principl
develop
hiv
envelop
variant
fundament
improv
biophys
properti
ysd
allow
display
million
sequenc
variant
select
base
flexibl
design
criteria
allow
effici
deep
coverag
envelop
structur
function
landscap
repres
potenti
enabl
technolog
rapid
translat
find
basic
studi
develop
novel
candid
immunogen
ysd
establish
power
method
engin
divers
protein
broad
rang
function
improv
includ
stabil
specif
affin
catalysi
enantioselect
routin
variant
millionfold
improv
isol
larg
librari
repeat
cycl
mutagenesi
select
result
evolut
highest
affin
synthet
interact
ever
observ
inde
promis
effort
aim
develop
scaffold
epitop
core
desir
properti
enhanc
recognit
germlin
antibodi
famili
routin
reli
upon
combinatori
approach
ysdbase
direct
evolut
howev
yeast
express
display
complet
much
less
describ
investig
yeast
host
display
hiv
spike
protein
variant
report
first
time
display
fulllength
cerevisia
jrfl
variant
sosip
mutat
serv
start
point
previous
engin
stabil
homogen
wellexpress
mammalian
cell
sosip
mutat
prove
key
enabl
structur
insight
nativ
envelop
trimer
appli
random
mutagenesi
dna
shuffl
combin
stringent
driven
select
isol
sosip
variant
significantli
enhanc
express
bind
conform
hiv
bnab
suggest
proper
antigen
yeastdisplay
sosip
variant
describ
demonstr
feasibl
product
hiv
envelop
yeast
advantag
robust
platform
evolv
variant
envelop
trimer
present
confirm
engin
ysd
may
prove
robust
platform
rapid
evolut
select
promis
vaccin
immunogen
sinc
hiv
spike
protein
highli
glycosyl
proteolyt
process
contain
numer
disulfid
bond
eukaryot
cell
appropri
protein
process
machineri
serv
host
display
function
protein
wherea
mammalian
cell
line
rel
slow
grow
achiev
singl
genotypephenotyp
linkag
requir
viral
transfect
rather
cumbersom
timeconsum
methodolog
yeast
cerevisia
robust
welldescrib
eukaryot
host
cellsurfac
display
yeast
capabl
display
complex
mammalian
glycoprotein
antibodi
fragment
fulllength
antibodi
peptidemhc
molecul
growth
factor
receptor
well
grow
number
viral
envelop
protein
fragment
thereof
hemagglutinin
core
dengu
e
protein
sarscov
west
nile
viru
envelop
hepat
c
viru
envelop
protein
suggest
display
hiv
envelop
protein
feasibl
principl
nevertheless
cerevisia
nlink
glycan
extend
mannoserich
though
p
pastori
yeast
strain
human
humanlik
nlink
glycosy
report
overcom
limit
investig
whether
heterolog
nglycosyl
yeast
major
effect
recognit
conform
antibodi
compar
jrfl
produc
either
cerevisia
strain
glycanengin
p
pastori
bind
panel
conform
bnab
mannoserich
nglycosyl
trim
humanlik
stem
engin
pichia
may
promot
proper
protein
fold
conform
ab
recognit
howev
found
pichiaproduc
display
clearli
improv
bind
profil
across
panel
bnab
fig
furthermor
p
pastorisproduc
appear
somewhat
fragment
western
blot
suggest
proteolyt
degrad
compar
cerevisia
therefor
wellestablish
character
display
system
cerevisia
chosen
host
hiv
spike
protein
display
sinc
secret
fulllength
jrfl
includ
stabil
so
substitut
sosip
jrfl
cerevisia
fail
fragment
gene
compar
level
secret
protein
strip
core
construct
describ
previous
trim
n
ctermini
fulllength
fulllength
sosip
well
lack
hydrophob
fusion
peptid
fig
notabl
protein
secret
fusion
studi
firstli
fragment
fulllength
could
secret
clearli
detect
level
fulllength
sosip
secondli
omiss
fusion
peptid
clearli
enhanc
secret
suggest
omiss
modif
may
also
improv
fulllength
secret
thirdli
collaps
near
expect
mw
kda
treatment
nglycosidas
pngase
f
suggest
extens
nglycosyl
fig
base
find
ration
design
jrfl
sosipbas
design
dsosip
modif
codon
optim
cerevisia
hydrophob
amino
acid
within
fusion
peptid
replac
structur
relat
hydrophil
residu
possibl
found
among
circul
viral
sequenc
fig
lastli
furin
proteas
cleavag
site
substitut
yeast
recognit
site
predict
intern
site
remov
compar
secret
protein
content
cell
cultur
supernat
found
dsosip
initi
jrfl
sosip
could
detect
signific
level
dsosip
variant
significantli
nglycosyl
collaps
pngase
ftreatment
fig
ration
design
dsosip
variant
mutant
disrupt
bind
site
specif
ab
bind
dsosip
display
fusion
protein
yeast
fig
compar
display
level
bind
panel
hiv
bnab
togeth
wellcharacter
fold
core
unrel
viral
envelop
protein
deriv
hepat
c
viru
hcv
posit
neg
control
fig
notabl
core
epitop
includ
dsosip
core
lack
mani
epitop
dsosip
includ
variabl
loop
epitop
fig
induc
yeast
cell
alway
includ
popul
display
heterolog
protein
featur
display
system
dsosip
construct
show
extrem
low
display
level
compar
core
fig
somewhat
background
bind
ab
fig
howev
standard
bind
hivspecif
ab
variabl
display
level
taken
account
lead
detect
bind
across
wide
rang
ab
specif
includ
conform
linear
glycandepend
site
yeastdisplay
dsosip
bound
well
ab
mper
ab
might
expect
due
abil
bind
unconstrain
peptid
surprisingli
low
reproduc
signal
observ
suggest
recognit
glycan
trimerpref
antibodi
fig
tabl
furthermor
dsosip
substitut
observ
reduc
bind
antibodi
nonetheless
low
signal
rel
core
mani
antibodi
test
clearli
indic
signific
room
improv
might
achiev
coupl
ration
design
modif
made
thu
far
direct
evolut
strategi
select
properli
fold
sequenc
variant
dsosip
librari
member
prepar
librari
member
contain
averag
random
amino
acid
mutat
tabl
conformationdepend
mab
specif
bind
discontinu
epitop
serv
molecular
probe
properli
fold
antigen
dsosip
librari
extens
screen
improv
bind
conformationdepend
bnab
mimic
natur
ligand
mode
bind
pool
clone
select
diversifi
member
two
addit
cycl
error
prone
pcr
repeat
fac
select
improv
bind
either
track
altern
enrich
base
bind
hiv
ab
track
pool
mix
five
mab
track
describ
tabl
mab
chosen
bind
conform
conserv
function
critic
differ
sequenc
paratop
minim
risk
select
specif
affinityenhanc
contact
residu
instead
gener
structur
stabil
mutat
compar
bind
analysi
initi
dsosip
select
pool
cycl
onward
show
enhanc
bind
target
bnab
also
nontarget
mab
suggest
gener
improv
structur
represent
conform
epitop
fig
significantli
differ
epitop
footprint
within
dna
sequenc
reveal
two
domin
distinct
cluster
sequenc
enrich
fig
select
combinatori
mutant
improv
bind
properti
among
cluster
remov
structur
disrupt
mutat
like
coselect
dsosip
pool
variant
dnashuffl
ratio
subject
addit
three
round
fac
follow
select
track
select
popul
pool
show
greatli
enhanc
express
bind
mab
compar
pool
select
dna
shuffl
fig
differ
bind
observ
track
fig
total
clone
select
track
evalu
bind
absenc
bind
two
neg
control
mab
use
aggreg
rank
analysi
clone
best
least
control
mab
bind
screen
broad
recognit
conform
mab
well
natur
ligand
membraneproxim
extracellular
region
mab
two
uniqu
clone
denot
identifi
rank
best
bind
specif
breath
hivspecif
recognit
dna
sequenc
refer
clone
enrich
dna
shuffl
reveal
total
amino
acid
substitut
respect
notabl
ident
region
differ
mutat
within
region
revert
dsosip
wild
type
clone
fig
show
greatli
improv
bind
sever
ab
neutral
nonneutr
also
ab
mper
ab
compar
initi
dsosip
perhap
surprisingli
improv
bind
natur
ligand
detect
bind
maintain
compar
level
dsosip
fig
determin
whether
enhanc
observ
display
variant
generaliz
secret
protein
clone
express
solubl
evolv
variant
subsequ
compar
yeastsecret
bind
envelopespecif
antibodi
notabl
refer
dsosip
could
secret
suffici
quantiti
yeast
bind
analys
line
extrem
low
display
level
dsosip
observ
yeast
cell
fig
beyond
enabl
express
clone
exhibit
improv
bind
number
mab
notabl
rel
fig
suggest
improv
bind
properti
observ
yeast
cell
correl
improv
bind
properti
solubl
map
mutat
crystal
structur
show
mutat
found
cluster
rel
narrow
region
within
loop
region
proxim
fig
side
chain
buri
within
protein
locat
small
caviti
appear
directli
contact
mab
fig
suggest
structur
stabil
mutat
select
interestingli
mutat
residu
may
form
hydrogen
bond
stabil
helic
within
inner
domain
similarli
may
form
novel
hydrogen
bond
fig
mutat
disrupt
nglycosyl
motif
locat
within
loop
region
three
addit
mutat
lost
shuffl
surfac
locat
suggest
surfaceloc
mutat
may
essenti
improv
protein
fold
yeast
mutat
found
within
could
map
due
disord
electron
densiti
particular
region
sosip
crystal
structur
sinc
show
virtual
ident
bind
profil
express
level
fig
mutat
appear
strongli
contribut
either
improv
protein
express
ab
recognit
key
attribut
effect
antivir
vaccin
respons
develop
antibodi
viral
envelop
protein
result
abil
prevent
clear
viral
infect
end
induct
neutral
antibodi
capabl
block
viral
infect
cornerston
hiv
vaccin
effort
howev
hiv
arsen
way
evad
antibodi
recognit
includ
multipl
conform
state
close
open
cleav
uncleav
trimer
variou
monomer
spike
protein
form
thought
distract
dilut
adapt
immun
respons
infecti
nativ
envelop
trimer
immunogen
design
effort
aim
circumv
barrier
stem
back
discoveri
hiv
bnab
began
identif
epitop
mimet
peptid
capabl
bind
high
affin
howev
vaccin
mimet
peptid
fail
induc
ab
bound
recent
approach
base
subtract
principl
immunogen
featur
antigen
lead
nonneutr
immunodomin
antibodi
respons
remov
mask
glycan
even
dramat
direct
graft
function
relev
site
onto
altern
scaffold
goal
focus
immun
respons
function
relev
epitop
subtract
altern
epitop
howev
may
activ
promot
respons
desir
epitop
may
rather
result
blunt
immun
respons
titer
ab
recogn
select
epitop
enhanc
total
antibodi
respons
decreas
mix
success
recent
report
effort
set
hiv
subtract
epitop
may
unnecessarili
constrain
immun
limit
potenti
protect
recal
cell
respons
nonproduct
decreas
polyclon
antibodi
respons
result
reduc
recruit
effector
mechan
reliant
avid
interact
antibodi
opson
cell
viru
effector
mechan
demonstr
import
prevent
acquisit
decreas
viral
burden
delay
progress
possibl
immunolog
outcom
vaccin
reduc
epitop
coverag
may
divid
rather
conquer
extens
studi
util
solubl
gener
fail
provid
protect
ab
respons
numer
fulllength
trimer
antigen
may
better
resembl
structur
nativ
spike
also
test
follow
rational
antibodi
recogn
nativ
trimer
spike
neutral
viru
sosip
trimer
fall
class
grow
number
envelop
sequenc
so
ip
mutat
individu
construct
test
culmin
trimer
complementari
approach
strictli
ration
develop
stabl
uniform
wellbehav
protein
combinatori
protein
engin
involv
screen
larg
librari
protein
mutant
display
virus
cell
improv
properti
affin
stabil
protein
express
toward
end
hiv
viru
particl
expos
temperatur
chemic
denatur
stress
screen
retain
infect
mammalian
cell
homogen
stabl
virus
could
select
follow
procedur
howev
cellular
protein
display
method
yeast
display
particular
stand
goldstandard
evolut
complex
glycosyl
protein
base
advantag
speed
librari
construct
scalabl
select
eas
use
applic
system
design
variant
jrfl
sosip
repres
first
use
highthroughput
platform
whole
envelop
evolut
eas
variant
improv
express
bind
conform
hiv
antibodi
could
evolv
repeat
round
random
mutagenesi
flowcytometr
select
point
toward
promis
util
mannoserich
glycosyl
cerevesia
theori
reduc
enthusiasm
host
major
class
bnab
includ
glycanspecif
ab
bound
yeastproduc
variant
loss
one
nglycosyl
motif
observ
select
improv
bind
observ
select
variant
exhibit
similar
bind
core
show
broadli
improv
bind
across
multipl
mab
suggest
gener
improv
structur
represent
epitop
whether
select
dsosip
variant
could
elicit
improv
neutral
immun
appli
immunogen
unclear
improv
antigen
equat
improv
immunogen
immun
studi
would
requir
evalu
abil
elicit
neutral
antibodi
differ
glycosyl
also
larg
impact
antigen
factor
optim
studi
importantli
yeast
util
glycosyl
motif
composit
glycan
incorpor
differ
significantli
could
engin
rather
consid
methodolog
describ
variant
enabl
platform
futur
investig
toward
develop
improv
immunogen
panel
divers
stabil
variant
thought
like
requir
cover
circul
viru
divers
minim
immun
escap
mutat
glycan
mask
elicit
broad
neutral
activ
nine
mutat
within
contribut
enhanc
properti
yeast
locat
rel
narrow
region
either
proxim
within
loop
domain
determin
homolog
model
interestingli
three
nine
mutat
may
form
novel
hydrogen
bond
predominantli
buri
locat
mutat
identifi
predict
presenc
addit
buri
hydrogen
bond
select
clone
suggest
poor
surfac
display
level
limit
bind
yeastdisplay
conform
ab
observ
initi
relat
poor
fold
cerevisia
improv
core
pack
hydrogen
bond
within
core
may
help
stabil
protein
enhanc
fold
result
higher
display
level
fact
display
level
protein
fuse
shown
previous
correl
thermal
stabil
solubl
express
level
yeast
known
contain
chaperon
machineri
retain
degrad
misfold
protein
accumul
mutat
within
loop
domain
suggest
region
addit
core
critic
impact
obstruct
proper
fold
find
support
notion
yeast
produc
core
lack
domain
bind
well
conform
ab
fulllength
contain
hydrophil
fusion
peptid
provid
critic
handl
ration
improv
express
dsosip
cerevisia
howev
addit
express
enhanc
appar
structur
stabil
mutat
identifi
evolv
dsosip
variant
evid
util
ration
mutat
found
absenc
revers
observ
among
select
clone
notabl
studi
provid
evid
display
trimer
yeast
steric
perspect
seem
unlik
due
clash
cell
wall
anchor
fusion
partner
engin
fusion
peptid
toward
reduc
hydrophob
may
conserv
possibl
effect
overal
trimer
structur
address
futur
studi
secretioncapturebas
display
system
could
develop
allow
evolut
trimer
spike
protein
librari
noncoval
link
engin
fusion
peptid
could
gradual
mutat
back
wildtyp
affect
trimer
structur
fusion
peptid
variant
could
select
yeastdisplay
librari
improv
trimerspecif
antibodi
recognit
summari
dsosip
variant
evolv
platform
approach
describ
provid
step
forward
toward
develop
promis
novel
hiv
immunogen
could
rapidli
iter
evalu
immun
studi
anim
model
evalu
could
help
elucid
valu
whole
envelop
strategi
rel
subtract
approach
focus
restrict
set
epitop
less
hydrophob
fusion
peptid
prove
critic
featur
achiev
initi
detect
express
level
allow
yeast
displaybas
cell
sort
shuffl
accumul
mutat
backcross
wild
type
greatli
boost
bind
target
hiv
mab
potenti
elimin
deleteri
mutat
variant
improv
bind
certain
hiv
bnab
germlin
precursor
follow
concept
bcelllineag
immunogen
design
may
evolv
rel
quickli
use
approach
describ
glycoengin
yeast
strain
could
serv
host
futur
yeastbas
display
system
select
spike
protein
variant
homogen
decor
humanlik
glycan
involv
bind
mani
bnabclass
evolv
yeastproduc
spike
protein
deriv
may
also
well
suit
solv
addit
spike
protein
structur
facilit
ration
vaccin
design
approach
contribut
immunogen
pipelin
pcr
product
prepar
use
proofread
phusion
dna
polymeras
finnzym
oligonucleotid
primer
integr
dna
technolog
unless
otherwis
state
dna
restrict
modifi
enzym
new
england
biolab
pcr
product
purifi
gelextract
use
kit
either
qiagen
geneaid
dna
sequenc
construct
verifi
use
appli
biosystem
model
dna
sequenc
e
coli
strain
alpha
use
host
molecular
clone
yeast
strain
cerevisia
p
pastori
research
corpor
technolog
use
host
solubl
protein
secret
cerevisia
cell
surfac
display
plasmid
solubl
protein
secret
p
pastori
strain
prepar
follow
jrfl
amplifi
use
primer
insert
ecori
xbai
site
plasmid
solubl
protein
secret
cerevisia
prepar
amplif
use
primer
jrflfor
jrflfor
jrflfor
insert
eagi
bamhi
site
plasmid
prsdsosip
yeast
codonoptim
design
jrfl
denot
dsosip
base
construct
insert
eagi
bamhi
site
dna
sequenc
dsosip
shown
fig
plasmid
pcha
obtain
kind
gift
jordi
matafink
plasmid
pchadsosip
cerevisia
cell
surfac
display
prepar
amplif
prsdsosip
use
primer
insert
pcr
product
nhei
bamhi
site
pcha
result
orient
ha
tag
dsosip
cmyc
tag
follow
n
c
termini
respect
prepar
use
primer
follow
quikchang
sitedirect
mutagenesi
procedur
agil
pcr
primer
list
tabl
secret
solubl
hiv
spike
protein
variant
lack
cellwal
anchor
domain
p
pastori
electrocompet
yeast
cell
prepar
describ
previous
transform
construct
plate
ypd
plate
contain
zeocin
invivo
gen
incub
c
day
obtain
singl
clone
typic
ml
ypd
cultur
contain
zeocin
inocul
overnight
precultur
grown
h
c
follow
day
c
constitut
protein
express
secret
solubl
hiv
spike
protein
variant
lack
cellwal
anchor
domain
cerevisia
chemic
compet
yeast
cell
prepar
transform
pr
construct
use
frozenez
yeast
transform
ii
kit
zymo
plate
sdcaa
plate
supplement
mgl
ltryptophan
incub
c
day
obtain
singl
clone
typic
ml
sdcaa
cultur
supplement
mgl
ltryptophan
inocul
overnight
precultur
grown
h
c
induct
protein
product
cell
spun
suspend
ml
sgcaa
medium
contain
mgl
ltryptophan
grown
day
c
media
composit
describ
previous
secret
spike
protein
variant
either
detect
directli
cultur
supernat
imacpurifi
bufferexchang
pb
prior
analysi
hiv
spike
protein
variant
display
cerevisia
decrib
previous
briefli
cerevisia
transform
pcha
construct
use
frozenez
yeast
transform
ii
kit
zymo
clone
grown
sdcaa
plate
c
typic
ml
sdcaa
medium
inocul
overnight
precultur
grown
c
h
transfer
sgcaa
medium
grown
h
c
induc
cell
analyz
cell
surfac
display
macsquant
analyz
miltenyi
biotec
typic
yeast
cell
suspend
pb
supplement
bsa
pbsf
plate
greiner
spun
min
g
supernat
remov
vacuum
aspir
cell
suspend
pbsf
contain
dilut
mous
monoclon
antiha
tag
antibodi
clone
covanc
chicken
polyclon
anticmyc
tag
antibodi
gallu
immunotechnolog
detect
display
level
human
hiv
antibodi
variou
concentr
incub
h
ambient
temperatur
shake
rpm
cell
wash
twice
pbsf
suspend
pbsf
contain
dilut
polyclon
goat
antimous
goat
antichicken
antibodi
goat
antihuman
antibodi
conjug
life
scienc
incub
min
ambient
temperatur
shake
cell
wash
suspend
pbsf
respect
kept
cold
flowcytometr
analys
routin
cell
gate
use
forward
side
scatter
median
fluoresc
intens
mfi
determin
scatterg
event
gate
display
signal
gate
display
level
set
use
nondisplay
control
sampl
assur
nondisplay
cell
exclud
mfi
valu
associ
antibodi
bind
normal
display
level
divis
mfi
associ
express
tag
nmfi
analys
perform
use
macsquantifi
softwar
miltenyi
yeastsecret
imac
purifi
denatur
min
c
load
nupag
novex
trisacet
gel
life
scien
v
appli
h
mop
buffer
life
scienc
gel
stain
use
gelcod
blue
stain
reagent
pierc
analyz
use
gel
doc
xr
system
biorad
western
blot
analys
hiv
spike
protein
variant
typic
denatur
reduc
crude
cultur
supernat
load
gel
blot
h
v
pores
pvdf
membran
life
scienc
membran
wash
twice
min
pb
block
h
pb
supplement
bsa
vv
tween
wash
twice
min
pb
supplement
vv
tween
pbst
pb
wash
membran
incub
ml
pb
contain
bsa
vv
tween
goat
polyclon
antibodi
hrp
conjug
abcam
detect
mous
monoclon
antihi
antibodi
hrp
conjug
qiagen
histag
detect
cover
transpar
membran
wash
incub
min
enhanc
chemiluminesc
substrat
pierc
analyz
use
gel
doc
xr
system
biorad
jrfl
librari
insert
prepar
base
protocol
fromant
et
al
aim
amino
acid
mutat
per
gene
reaction
contain
datp
dctp
dgtp
mm
dttp
pm
pchadsosip
templat
dna
nm
primer
nm
primer
bsa
mm
u
taq
dna
polymeras
neb
mm
kcl
mm
trishcl
ph
c
thermocycl
condit
c
min
follow
cycl
c
min
c
min
c
min
final
c
min
pcr
product
columnpurifi
ng
use
templat
amplif
total
pcr
reaction
volum
use
phusion
dna
polymeras
primer
thermocycl
condit
c
min
follow
cycl
c
c
c
min
final
c
min
librari
vector
prepar
cleav
u
bamhi
nhei
respect
ml
final
volum
h
c
follow
addit
anoth
u
enzym
dtt
mm
incub
night
c
reaction
heatinactiv
min
c
vector
gelextract
use
dna
extract
maxi
kit
geneaid
insert
vector
prepar
ethanolprecipit
wash
concentr
pellet
paint
coprecipit
millipor
suspend
final
volum
approxim
insert
vector
total
electrocompet
cerevisia
prepar
essenti
describ
previous
mix
insert
vector
split
eight
mm
cuvett
transform
kv
uf
use
gene
pulser
xcell
biorad
transform
cell
grown
typic
ml
sdcaa
medium
passag
least
prior
induct
fac
librari
size
determin
plate
dilut
transform
sdcaa
plate
count
coloni
dna
encod
enrich
design
variant
shuffl
base
protocol
stemmer
briefli
pcr
product
incub
u
dnasei
exactli
min
c
respect
follow
immedi
heatinactiv
c
min
reaction
separ
agaros
gel
fragment
bp
kb
gelextract
approxim
ng
digest
select
pool
assembl
ng
digest
initi
dsosip
reaction
use
phusion
dna
polymeras
c
follow
cycl
c
c
c
final
min
c
exactli
assembl
product
amplifi
reaction
use
primer
phusion
dna
polymeras
min
c
cycl
c
c
min
c
final
min
c
assembl
pcr
product
ethanolprecipit
wash
concentr
use
librari
prepar
describ
previou
section
freshli
grown
yeast
librari
dilut
oversampl
librari
size
least
grown
least
h
c
shake
rpm
cell
sediment
suspend
sgcaa
medium
induc
least
h
c
induc
cell
filter
use
mesh
bd
bioscienc
typic
cell
wash
time
ml
pbsf
incub
h
ambient
temperatur
vari
concentr
hiv
antibodi
tabl
option
dilut
chicken
polyclon
anticmyc
tag
antibodi
gallu
immunotechnolog
pbsf
cell
wash
twice
ml
pbsf
stain
min
ice
dilut
goat
antihuman
polyclon
antibodi
conjug
life
scienc
option
goat
antichicken
polyclon
antibodi
conjug
life
scienc
shield
light
cell
wash
twice
split
four
aliquot
kept
pellet
ice
shield
light
sort
fac
perform
use
icyt
cell
sorter
system
soni
briefli
aliquot
typic
stain
yeast
cell
suspend
ml
pbsf
sort
around
eventss
use
sort
gate
recoveri
mode
initi
ultra
puriti
mode
later
sort
cycl
typic
sort
gate
initi
later
select
round
shown
fig
sort
cell
suspend
sdcaa
medium
grown
h
subsequ
sort
round
analys
select
pool
bind
analys
perform
c
use
octet
system
fortebio
rpm
shake
speed
pb
contain
bsa
vv
sampl
buffer
protein
acoat
biosensor
tip
load
min
igg
dip
buffer
probe
nm
min
follow
dissoci
phase
min
buffer
trace
obtain
igg
probe
buffer
subtract
refer
crystal
structur
use
model
taken
chain
site
determin
use
pymol
interfac
residu
script
cocryst
structur
pdb
id
map
correspond
side
chain
mutat
dsosip
pick
select
map
onto
sosip
structur
via
sequenc
align
side
chain
rotam
minim
clash
chosen
hydrogen
bond
design
distanc
mutat
map
due
lack
resolut
crystal
structur
